Novanta (NASDAQ:NOVT) Updates FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVTGet Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share guidance of 3.500-3.650 for the period, compared to the consensus earnings per share estimate of 3.560. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.0 billion. Novanta also updated its Q2 2026 guidance to 0.810-0.860 EPS.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Wall Street Zen lowered shares of Novanta from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a report on Friday, April 17th. Robert W. Baird raised shares of Novanta from a “neutral” rating to an “outperform” rating and lowered their price target for the company from $150.00 to $144.00 in a report on Monday, March 30th. Finally, Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Novanta has an average rating of “Hold” and a consensus price target of $144.00.

Read Our Latest Stock Report on Novanta

Novanta Trading Up 1.2%

NOVT traded up $1.65 during trading on Monday, reaching $139.96. 612,672 shares of the company’s stock were exchanged, compared to its average volume of 420,164. The company’s fifty day moving average price is $125.83 and its 200-day moving average price is $125.05. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69. Novanta has a fifty-two week low of $98.27 and a fifty-two week high of $149.95. The firm has a market capitalization of $4.98 billion, a PE ratio of 95.86 and a beta of 1.62.

Novanta (NASDAQ:NOVTGet Free Report) last released its earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.04. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $257.71 million during the quarter, compared to analyst estimates of $253.40 million. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, equities analysts forecast that Novanta will post 3.54 EPS for the current year.

Insiders Place Their Bets

In other Novanta news, CFO Robert Buckley sold 9,957 shares of Novanta stock in a transaction on Monday, March 16th. The shares were sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the completion of the sale, the chief financial officer owned 96,616 shares of the company’s stock, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Matthijs Glastra sold 6,500 shares of Novanta stock in a transaction on Friday, April 17th. The stock was sold at an average price of $130.05, for a total transaction of $845,325.00. Following the sale, the chief executive officer directly owned 56,761 shares of the company’s stock, valued at $7,381,768.05. This represents a 10.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 25,380 shares of company stock valued at $3,296,276 in the last ninety days. Company insiders own 1.20% of the company’s stock.

Hedge Funds Weigh In On Novanta

Institutional investors and hedge funds have recently made changes to their positions in the company. Corient Private Wealth LLC bought a new stake in Novanta in the 4th quarter valued at $275,000. Invesco Ltd. lifted its position in Novanta by 9.0% in the 4th quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock valued at $8,102,000 after acquiring an additional 5,600 shares in the last quarter. Alberta Investment Management Corp bought a new stake in Novanta in the 4th quarter valued at $1,285,000. Mercer Global Advisors Inc. ADV bought a new stake in Novanta in the 4th quarter valued at $314,000. Finally, Empowered Funds LLC lifted its position in Novanta by 16.7% in the 4th quarter. Empowered Funds LLC now owns 7,888 shares of the technology company’s stock valued at $939,000 after acquiring an additional 1,128 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Company Profile

(Get Free Report)

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

Featured Articles

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.